MiniMed Group

Develops and sells integrated diabetes-management systems for people with diabetes who use insulin. The portfolio brings together insulin pumps, continuous glucose monitors, infusion sets and reservoirs, smart insulin pens, dosing algorithms, apps, and digital-care services. Revenue comes from reusable hardware and recurring sensors, supplies, software, and services sold to individuals, distributors, health-care providers, and institutions.

Serves pump users across an international footprint, with much of sales generated outside the United States and manufacturing in California and Puerto Rico. Its automated insulin-delivery systems combine a pump, compatible sensor, infusion set, reservoir, and dosing algorithm, while CareLink connects therapy data with patients, caregivers, and clinicians. Execution depends on safety and quality controls, reimbursement and distribution access, sole-source suppliers, Abbott’s sensor partnership, and transitional services from Medtronic, which retains voting control.